Antibodies to myelin‐associated glycoprotein (anti‐Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients
- 19 March 2008
- journal article
- case report
- Published by Wiley in Muscle & Nerve
- Vol. 37 (4), 490-495
- https://doi.org/10.1002/mus.20955
Abstract
We have examined whether antibodies to myelin‐associated glycoprotein (anti‐MAG) influence neuropathy occurrence and phenotype in primary (AL IgM) amyloidosis. Anti‐MAG and the cross‐reacted sulfoglucuronyl paragloboside antibodies (SGPG) were studied in 46 patients with IgM amyloidosis (21 with polyneuropathy), and 21 matched IgM MGUS (monoclonal gammopathies of undetermined significance) controls without neuropathy. We assessed the occurrence, phenotype of neuropathy, and attributes of nerve conduction and their relation to antibody activity. Twenty of 46 patients with IgM amyloidosis (7 with and 13 without polyneuropathy) had elevation of anti‐MAG or SGPG by enzyme‐linked immunosorbent assay (ELISA). Two of the polyneuropathy patients with IgM amyloidosis had antibodies to MAG based on Western blot (WB) positivity. One of these patients, with the highest anti‐MAG titer, had a painful sensory ataxia, with prominent demyelination, and amyloid deposition in sural nerve. The other anti‐MAG WB‐positive amyloid patient had an axonal neuropathy and dysautonomia. Low levels of anti‐MAG antibodies were found in 12 of 21 IgM MGUS controls without neuropathy (mean follow‐up, 11 years). We conclude that finding serum anti‐MAG antibodies does not exclude the diagnosis of primary amyloidosis. They do not appear to affect the occurrence or expression of polyneuropathy, except possibly in occasional cases with WB positivity. Muscle Nerve, 2007Keywords
This publication has 15 references indexed in Scilit:
- Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studiesActa Neurologica Scandinavica, 2009
- Terminal latency index in neuropathy with antibodies against myelin‐associated glycoproteinsMuscle & Nerve, 2007
- Amyloidosis and NeuropathyPublished by Elsevier BV ,2005
- Long-term Follow-up of 241 Patients With Monoclonal Gammopathy of Undetermined Significance: The Original Mayo Clinic Series 25 Years LaterMayo Clinic Proceedings, 2004
- Peripheral neuropathy associated with IgM monoclonal gammopathy: Correlations between M-protein antibody activity and clinical/electrophysiological features in 40 casesMuscle & Nerve, 1998
- Selective loss of myelin-associated glycoprotein from myelin correlates with anti-MAG antibody titre in demyelinating paraproteinaemic polyneuropathyBrain, 1996
- Polyneuropathy associated with monoclonal gammopathy of undetermined significanceNeurology, 1993
- Neuropathy associated with monoclonal gammopathies of undetermined significanceAnnals of Neurology, 1991
- Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti‐MAG IgM M‐proteinNeurology, 1987
- Amyloid Deposits and AmyloidosisNew England Journal of Medicine, 1980